Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction
Clinical trial NCT07172659 · RECRUITING
Trial details
- NCT number
- NCT07172659
- Sponsor
- Medicines Development for Global Health
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-25
- Primary completion
- 2027-01-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.